TG Therapeutics Statistics
Total Valuation
TGTX has a market cap or net worth of $2.15 billion. The enterprise value is $2.04 billion.
| Market Cap | 2.15B |
| Enterprise Value | 2.04B |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, before market open.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TGTX has 154.54 million shares outstanding. The number of shares has increased by 9.67% in one year.
| Shares Outstanding | 154.54M |
| Shares Change (YoY) | +9.67% |
| Shares Change (QoQ) | +0.19% |
| Owned by Insiders (%) | 9.08% |
| Owned by Institutions (%) | 59.28% |
| Float | 135.51M |
Valuation Ratios
The trailing PE ratio is 154.56 and the forward PE ratio is 140.85.
| PE Ratio | 154.56 |
| Forward PE | 140.85 |
| PS Ratio | 9.20 |
| Forward PS | 8.27 |
| PB Ratio | 13.39 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 161.00 |
| EV / Sales | 8.73 |
| EV / EBITDA | 78.81 |
| EV / EBIT | 79.46 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.92, with a Debt / Equity ratio of 0.68.
| Current Ratio | 5.92 |
| Quick Ratio | 5.02 |
| Debt / Equity | 0.68 |
| Debt / EBITDA | 4.22 |
| Debt / FCF | n/a |
| Interest Coverage | 2.04 |
Financial Efficiency
Return on equity (ROE) is 12.90% and return on invested capital (ROIC) is 7.42%.
| Return on Equity (ROE) | 12.90% |
| Return on Assets (ROA) | 4.70% |
| Return on Capital (ROIC) | 7.42% |
| Revenue Per Employee | $885,083 |
| Profits Per Employee | $48,000 |
| Employee Count | 264 |
| Asset Turnover | 0.87 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TGTX has paid $390,000 in taxes.
| Income Tax | 390,000 |
| Effective Tax Rate | 2.99% |
Stock Price Statistics
The stock price has decreased by -37.85% in the last 52 weeks. The beta is 2.32, so TGTX's price volatility has been higher than the market average.
| Beta (1Y) | 2.32 |
| 52-Week Price Change | -37.85% |
| 50-Day Moving Average | 15.07 |
| 200-Day Moving Average | 13.54 |
| Relative Strength Index (RSI) | 39.45 |
| Average Volume (30 Days) | 3,486,824 |
Short Selling Information
The latest short interest is 35.71 million, so 23.11% of the outstanding shares have been sold short.
| Short Interest | 35.71M |
| Short Previous Month | 34.36M |
| Short % of Shares Out | 23.11% |
| Short % of Float | 26.35% |
| Short Ratio (days to cover) | 14.61 |
Income Statement
In the last 12 months, TGTX had revenue of $233.66 million and earned $12.67 million in profits. Earnings per share was $0.09.
| Revenue | 233.66M |
| Gross Profit | 219.53M |
| Operating Income | 20.63M |
| Pretax Income | 13.06M |
| Net Income | 12.67M |
| EBITDA | 25.89M |
| EBIT | 25.68M |
| Earnings Per Share (EPS) | $0.09 |
Balance Sheet
The company has $218.79 million in cash and $109.35 million in debt, giving a net cash position of $109.44 million or $0.71 per share.
| Cash & Cash Equivalents | 218.79M |
| Total Debt | 109.35M |
| Net Cash | 109.44M |
| Net Cash Per Share | $0.71 |
| Equity / Book Value | 160.50M |
| Book Value Per Share | 1.04 |
| Working Capital | 264.22M |
Cash Flow
| Operating Cash Flow | -31.41M |
| Capital Expenditures | n/a |
| Free Cash Flow | -31.41M |
| FCF Per Share | -$0.22 |
Margins
Gross margin is 93.95%, with operating and profit margins of 8.83% and 5.42%.
| Gross Margin | 93.95% |
| Operating Margin | 8.83% |
| Pretax Margin | 5.59% |
| Profit Margin | 5.42% |
| EBITDA Margin | 11.08% |
| EBIT Margin | 10.99% |
| FCF Margin | -13.44% |
Dividends & Yields
TGTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.67% |
| Shareholder Yield | -9.67% |
| Earnings Yield | 0.59% |
| FCF Yield | -1.46% |
Analyst Forecast
The average price target for TGTX is $30.20, which is 117.11% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.20 |
| Price Target Difference | 117.11% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 42.77% |
| EPS Growth Forecast (5Y) | 123.17% |
Stock Splits
The last stock split was on April 30, 2012. It was a reverse split with a ratio of 100:5625.
| Last Split Date | Apr 30, 2012 |
| Split Type | Reverse |
| Split Ratio | 100:5625 |
Scores
TGTX has an Altman Z-Score of 3.12 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.12 |
| Piotroski F-Score | 5 |